| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1C SLC46A2 ABCA13 GJB4 TMC6 HTR3E TMEM175 ABCC9 PANX2 SLC30A3 SLCO6A1 SLC4A1 SLC32A1 CATSPER1 CLCN3 CLCN5 CLCN6 MIP SCN8A SLC10A6 TMC8 SLC38A6 SLC25A45 | 6.49e-08 | 1180 | 108 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1C SLC46A2 ABCA13 GJB4 TMC6 HTR3E TMEM175 ABCC9 APOB PANX2 SLC30A3 SLCO6A1 SLC4A1 SLC32A1 CATSPER1 CLCN3 CLCN5 CLCN6 MIP SCN8A SLC10A6 TMC8 SLC38A6 SLC25A45 | 7.49e-08 | 1289 | 108 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | channel activity | CACNA1C GJB4 TMC6 HTR3E TMEM175 ABCC9 PANX2 CATSPER1 CLCN3 CLCN5 CLCN6 MIP SCN8A TMC8 | 9.22e-07 | 525 | 108 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1C GJB4 TMC6 HTR3E TMEM175 ABCC9 PANX2 CATSPER1 CLCN3 CLCN5 CLCN6 MIP SCN8A TMC8 | 9.43e-07 | 526 | 108 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C TMC6 HTR3E TMEM175 ABCC9 SLC30A3 SLC4A1 SLC32A1 CATSPER1 CLCN3 CLCN5 CLCN6 SCN8A SLC10A6 TMC8 | 2.37e-05 | 793 | 108 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.46e-05 | 11 | 108 | 3 | GO:0005247 | |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 2.90e-05 | 2 | 108 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC46A2 SLC30A3 SLCO6A1 SLC4A1 SLC32A1 CLCN3 CLCN5 CLCN6 SLC10A6 | 3.32e-05 | 296 | 108 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C TMC6 HTR3E TMEM175 ABCC9 CATSPER1 CLCN3 CLCN5 CLCN6 SCN8A TMC8 | 3.91e-05 | 459 | 108 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A2 ABCA13 ABCC9 SLC30A3 SLCO6A1 SLC4A1 SLC32A1 CLCN3 CLCN5 CLCN6 SLC10A6 | 5.53e-05 | 477 | 108 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | gated channel activity | 8.42e-05 | 334 | 108 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 9.90e-05 | 17 | 108 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.05e-04 | 138 | 108 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C TMEM175 ABCC9 SLC30A3 SLC4A1 SLC32A1 CATSPER1 CLCN3 CLCN5 CLCN6 MIP SCN8A SLC10A6 | 2.28e-04 | 758 | 108 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.68e-04 | 182 | 108 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.96e-04 | 184 | 108 | 6 | GO:0022832 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1C TMC6 HTR3E TMEM175 ABCC9 PANX2 ACE SLC30A3 ALG10B SLC4A1 SLC32A1 CATSPER1 CLCN3 CLCN5 CLCN6 PIK3C2A ALG10 SCN8A SLC10A6 TMC8 CNTN1 | 6.66e-06 | 1374 | 107 | 21 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1C TMC6 HTR3E TMEM175 ABCC9 PANX2 SLC30A3 ALG10B SLC4A1 SLC32A1 CATSPER1 CLCN3 CLCN5 CLCN6 PIK3C2A ALG10 SCN8A TMC8 | 1.62e-05 | 1115 | 107 | 18 | GO:0034220 |
| GeneOntologyCellularComponent | endosome | SLC46A2 ZFYVE27 TMEM175 APOB ACE SLC30A3 WDFY4 CRHBP IFNAR1 TMEM106B CLCN3 CLCN5 CLCN6 SBF2 RASGEF1B CD79A RAB40B CX3CR1 DOP1A DOP1B | 2.28e-06 | 1167 | 109 | 20 | GO:0005768 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | LMF1 FMO2 ZFYVE27 UGT1A5 TMC6 SEC22B APOB HMGCR FTCD PANX2 ALG10B TMEM260 TMEM259 LPCAT3 ALG10 TMC8 UGT2B4 NDRG4 MAN1B1 | 3.68e-05 | 1293 | 109 | 19 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | LMF1 FMO2 ZFYVE27 UGT1A5 TMC6 SEC22B APOB HMGCR FTCD PANX2 ALG10B TMEM260 TMEM259 LPCAT3 ALG10 TMC8 UGT2B4 NDRG4 MAN1B1 | 3.92e-05 | 1299 | 109 | 19 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | LMF1 FMO2 ZFYVE27 UGT1A5 TMC6 SEC22B APOB HMGCR FTCD PANX2 ALG10B TMEM260 TMEM259 LPCAT3 ALG10 TMC8 UGT2B4 NDRG4 MAN1B1 | 5.23e-05 | 1327 | 109 | 19 | GO:0042175 |
| GeneOntologyCellularComponent | endosome membrane | SLC46A2 ZFYVE27 TMEM175 APOB SLC30A3 TMEM106B CLCN3 CLCN5 CLCN6 SBF2 CX3CR1 DOP1B | 7.19e-05 | 602 | 109 | 12 | GO:0010008 |
| GeneOntologyCellularComponent | Golgi membrane | MANEA SEC22B FTCD PANX2 CLCN3 CLCN5 ST8SIA6 GLCE WSCD2 SMPD3 PAQR3 DOP1A DOP1B | 9.76e-05 | 721 | 109 | 13 | GO:0000139 |
| GeneOntologyCellularComponent | vacuole | ABCA13 TMEM175 HGSNAT APOB ACE SLC30A3 CRHBP IFNAR1 TMEM106B CLCN3 CLCN5 CLCN6 SBF2 CAP1 | 2.82e-04 | 913 | 109 | 14 | GO:0005773 |
| GeneOntologyCellularComponent | lysosome | ABCA13 TMEM175 HGSNAT APOB ACE SLC30A3 CRHBP IFNAR1 TMEM106B CLCN3 CLCN5 CLCN6 CAP1 | 3.09e-04 | 811 | 109 | 13 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | ABCA13 TMEM175 HGSNAT APOB ACE SLC30A3 CRHBP IFNAR1 TMEM106B CLCN3 CLCN5 CLCN6 CAP1 | 3.09e-04 | 811 | 109 | 13 | GO:0000323 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC46A2 ZFYVE27 ABCA13 TMC6 TMEM175 HGSNAT SEC22B APOB SLC30A3 SLC32A1 TMEM106B CLCN3 CLCN5 CLCN6 SBF2 CX3CR1 DOP1B | 4.21e-04 | 1307 | 109 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | late endosome | 4.81e-04 | 348 | 109 | 8 | GO:0005770 | |
| GeneOntologyCellularComponent | vesicle membrane | SLC46A2 ZFYVE27 ABCA13 TMC6 TMEM175 HGSNAT SEC22B APOB SLC30A3 SLC32A1 TMEM106B CLCN3 CLCN5 CLCN6 SBF2 CX3CR1 DOP1B | 4.92e-04 | 1325 | 109 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | gap junction | 9.42e-04 | 37 | 109 | 3 | GO:0005921 | |
| GeneOntologyCellularComponent | vacuolar membrane | ABCA13 TMEM175 HGSNAT SLC30A3 TMEM106B CLCN3 CLCN5 CLCN6 SBF2 | 1.35e-03 | 507 | 109 | 9 | GO:0005774 |
| GeneOntologyCellularComponent | cation channel complex | 1.46e-03 | 235 | 109 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.78e-03 | 46 | 109 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | presynapse | CACNA1C SEC22B SLC30A3 CRHBP SLC32A1 NF1 CLCN3 CLCN5 SCN8A RAB40B CAP1 CNTN1 | 2.25e-03 | 886 | 109 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | CatSper complex | 2.71e-03 | 15 | 109 | 2 | GO:0036128 | |
| GeneOntologyCellularComponent | lysosomal membrane | 2.91e-03 | 462 | 109 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.91e-03 | 462 | 109 | 8 | GO:0098852 | |
| Domain | Cl-channel_core | 1.58e-05 | 9 | 109 | 3 | IPR014743 | |
| Domain | - | 1.58e-05 | 9 | 109 | 3 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.58e-05 | 9 | 109 | 3 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.58e-05 | 9 | 109 | 3 | IPR001807 | |
| Domain | Alg10 | 3.37e-05 | 2 | 109 | 2 | IPR016900 | |
| Domain | Dopey_N | 3.37e-05 | 2 | 109 | 2 | IPR007249 | |
| Domain | DIE2_ALG10 | 3.37e-05 | 2 | 109 | 2 | PF04922 | |
| Domain | Dopey_N | 3.37e-05 | 2 | 109 | 2 | PF04118 | |
| Domain | CBS | 1.02e-04 | 16 | 109 | 3 | SM00116 | |
| Domain | CBS_dom | 2.05e-04 | 20 | 109 | 3 | IPR000644 | |
| Domain | CBS | 2.05e-04 | 20 | 109 | 3 | PF00571 | |
| Domain | CBS | 2.05e-04 | 20 | 109 | 3 | PS51371 | |
| Domain | TMC | 9.24e-04 | 8 | 109 | 2 | PF07810 | |
| Domain | TMC | 9.24e-04 | 8 | 109 | 2 | IPR012496 | |
| Domain | GRAM | 3.84e-03 | 16 | 109 | 2 | SM00568 | |
| Domain | Aa_trans | 4.33e-03 | 17 | 109 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 4.33e-03 | 17 | 109 | 2 | IPR013057 | |
| Domain | Channel_four-helix_dom | 4.50e-03 | 57 | 109 | 3 | IPR027359 | |
| Domain | - | 4.50e-03 | 57 | 109 | 3 | 1.20.120.350 | |
| Pubmed | Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. | 1.23e-07 | 4 | 110 | 3 | 17110406 | |
| Pubmed | Expression of CLCN voltage-gated chloride channel genes in human blood vessels. | 6.11e-07 | 6 | 110 | 3 | 10198195 | |
| Pubmed | 8.01e-07 | 23 | 110 | 4 | 12955145 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C LMF1 TTC21A TMC6 RNF213 TEP1 FBXO16 FAM120A TSPAN10 PCNX4 LPCAT3 SBF2 NT5C2 RAB40B CNOT1 MAN1B1 DOP1A INVS | 9.96e-07 | 1489 | 110 | 18 | 28611215 |
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 2.55e-06 | 9 | 110 | 3 | 23115349 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 5.57e-06 | 139 | 110 | 6 | 16985003 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 5.77e-06 | 37 | 110 | 4 | 25798587 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19524556 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 30191727 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23737750 | ||
| Pubmed | Partial Protection From Lupus-Like Disease by B-Cell Specific Type I Interferon Receptor Deficiency. | 9.91e-06 | 2 | 110 | 2 | 33488628 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 33583067 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26227733 | ||
| Pubmed | Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. | 9.91e-06 | 2 | 110 | 2 | 19706093 | |
| Pubmed | Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. | 9.91e-06 | 2 | 110 | 2 | 12426567 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22761942 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29846435 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10931277 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27137488 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 39095477 | ||
| Pubmed | Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. | 9.91e-06 | 2 | 110 | 2 | 21387292 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26126409 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25378492 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10844558 | ||
| Pubmed | Chloride/proton antiporters ClC3 and ClC5 support bone formation in mice. | 9.91e-06 | 2 | 110 | 2 | 38666049 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21157378 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 16271875 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27097911 | ||
| Pubmed | Merkel cell polyomavirus detection in a patient with familial epidermodysplasia verruciformis. | 9.91e-06 | 2 | 110 | 2 | 23535066 | |
| Pubmed | Sec22b is a critical and nonredundant regulator of plasma cell maintenance. | 9.91e-06 | 2 | 110 | 2 | 36595686 | |
| Pubmed | TMEM106B regulates microglial proliferation and survival in response to demyelination. | 9.91e-06 | 2 | 110 | 2 | 37146150 | |
| Pubmed | 1.28e-05 | 45 | 110 | 4 | 25979088 | ||
| Pubmed | 2.81e-05 | 493 | 110 | 9 | 15368895 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 12409258 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25661185 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 11727199 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 23534907 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 24303013 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25470345 | ||
| Pubmed | Ontogeny of CLCN3 chloride channel gene expression in human pulmonary epithelium. | 2.97e-05 | 3 | 110 | 2 | 11306429 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 20133873 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 15223114 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 30282022 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 30044661 | ||
| Pubmed | The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses. | 2.97e-05 | 3 | 110 | 2 | 30068544 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 35443157 | ||
| Pubmed | Presynaptic CLC-3 determines quantal size of inhibitory transmission in the hippocampus. | 2.97e-05 | 3 | 110 | 2 | 21378974 | |
| Pubmed | Microglial Remodeling of the Extracellular Matrix Promotes Synapse Plasticity. | 2.97e-05 | 3 | 110 | 2 | 32615087 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 32917726 | ||
| Pubmed | Type I interferon-activated microglia are critical for neuromyelitis optica pathology. | 2.97e-05 | 3 | 110 | 2 | 33241604 | |
| Pubmed | A Microbiota-Dependent Subset of Skin Macrophages Protects Against Cutaneous Bacterial Infection. | 2.97e-05 | 3 | 110 | 2 | 35757750 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 29420261 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 11359065 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 27899077 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 37449644 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 36809763 | ||
| Pubmed | Five polymorphisms in gene candidates for cardiovascular disease in Afro-Brazilian individuals. | 2.97e-05 | 3 | 110 | 2 | 15543563 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 33183319 | ||
| Pubmed | Insertional mutation of the motor endplate disease (med) locus on mouse chromosome 15. | 2.97e-05 | 3 | 110 | 2 | 7601440 | |
| Pubmed | Mon2, a relative of large Arf exchange factors, recruits Dop1 to the Golgi apparatus. | 2.97e-05 | 3 | 110 | 2 | 16301316 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 18158319 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 35303081 | ||
| Pubmed | Genome-wide association study identifies five new schizophrenia loci. | 5.21e-05 | 23 | 110 | 3 | 21926974 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 5.44e-05 | 208 | 110 | 6 | 33230847 | |
| Pubmed | 5.87e-05 | 66 | 110 | 4 | 19898482 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 29632086 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 28959042 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 37348508 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 20351103 | ||
| Pubmed | GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites. | 5.92e-05 | 4 | 110 | 2 | 30675063 | |
| Pubmed | The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. | 5.92e-05 | 4 | 110 | 2 | 14525949 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 33108405 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 27158906 | ||
| Pubmed | 5.94e-05 | 24 | 110 | 3 | 22534482 | ||
| Pubmed | Common variants at ten loci influence QT interval duration in the QTGEN Study. | 6.73e-05 | 25 | 110 | 3 | 19305408 | |
| Pubmed | 8.35e-05 | 568 | 110 | 9 | 9110174 | ||
| Pubmed | Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. | 9.85e-05 | 5 | 110 | 2 | 9514948 | |
| Pubmed | Close linkage of three neuronal genes on distal mouse chromosome 15. | 9.85e-05 | 5 | 110 | 2 | 8703126 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 34982959 | ||
| Pubmed | A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval. | 9.85e-05 | 5 | 110 | 2 | 22726844 | |
| Pubmed | Blood monocyte-derived CD169+ macrophages contribute to antitumor immunity against glioblastoma. | 9.85e-05 | 5 | 110 | 2 | 36266311 | |
| Pubmed | Inv acts as a molecular anchor for Nphp3 and Nek8 in the proximal segment of primary cilia. | 9.85e-05 | 5 | 110 | 2 | 20169535 | |
| Pubmed | Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment. | 9.85e-05 | 5 | 110 | 2 | 31112137 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 25765938 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 30282750 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 20570668 | ||
| Pubmed | Droplet-based forward genetic screening of astrocyte-microglia cross-talk. | 9.85e-05 | 5 | 110 | 2 | 36893254 | |
| Pubmed | Apoptotic cell fragments locally activate tingible body macrophages in the germinal center. | 9.85e-05 | 5 | 110 | 2 | 36868219 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 37414907 | ||
| Pubmed | USP18 lack in microglia causes destructive interferonopathy of the mouse brain. | 9.85e-05 | 5 | 110 | 2 | 25896511 | |
| Pubmed | Antimicrobial immunity impedes CNS vascular repair following brain injury. | 9.85e-05 | 5 | 110 | 2 | 34556874 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 19339555 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NCAPD3 RNF213 LANCL1 MANEA SEC22B HMGCR TMEM106B NF1 TMEM259 LPCAT3 GLCE TMEM231 MAN1B1 | 1.11e-04 | 1201 | 110 | 13 | 35696571 |
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 16029194 | ||
| Pubmed | Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression. | 1.47e-04 | 6 | 110 | 2 | 1352323 | |
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 32066949 | ||
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 37130522 | ||
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 23734214 | ||
| Pubmed | Two sequential activation modules control the differentiation of protective T helper-1 (Th1) cells. | 1.47e-04 | 6 | 110 | 2 | 33773107 | |
| Pubmed | 1.87e-04 | 35 | 110 | 3 | 22688191 | ||
| Cytoband | 17q25.3 | 4.75e-06 | 101 | 110 | 5 | 17q25.3 | |
| GeneFamily | Chloride voltage-gated channels | 7.12e-06 | 10 | 72 | 3 | 302 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 1.56e-05 | 2 | 72 | 2 | 448 | |
| GeneFamily | Solute carriers | SLC46A2 SLC30A3 SLCO6A1 SLC4A1 SLC32A1 SLC10A6 SLC38A6 SLC25A45 | 1.71e-04 | 395 | 72 | 8 | 752 |
| GeneFamily | Transmembrane channel likes | 4.31e-04 | 8 | 72 | 2 | 1135 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 3.72e-03 | 78 | 72 | 3 | 262 | |
| ToppCell | 10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue | 5.37e-06 | 178 | 110 | 6 | d10ed2543c96e1a2373f847e0b82144771e26d07 | |
| ToppCell | 10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue | 5.37e-06 | 178 | 110 | 6 | 8fc5f735afa25ae43c2acb1c710ade6e9e093e3c | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 188 | 110 | 6 | f1a9d8ea174a4bef0fae8188e3bd96b7ac1a39bb | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.04e-06 | 195 | 110 | 6 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-05 | 134 | 110 | 5 | 3b67c02b430b6d58467f36e606c478d3eea0063f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-05 | 143 | 110 | 5 | 57ee1830d96d73d92b5f83b028592a5d952c6013 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-05 | 151 | 110 | 5 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.84e-05 | 160 | 110 | 5 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.98e-05 | 161 | 110 | 5 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 166 | 110 | 5 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 166 | 110 | 5 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 5.76e-05 | 166 | 110 | 5 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 6.27e-05 | 169 | 110 | 5 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-05 | 169 | 110 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 170 | 110 | 5 | 28fb192b21cdc5a77ba4f276694cff852eb2304b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 170 | 110 | 5 | 239cb4b801b2d71a6facb386f2684c0851504151 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 6.45e-05 | 170 | 110 | 5 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.45e-05 | 170 | 110 | 5 | 6686d1797988216c0d9417f21a2537369abce410 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-05 | 171 | 110 | 5 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | 0385d5834ae16bbb0c6a68893fec60e4dd1e478d | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | a3e3fe0cbab21abb178c482f5951e576529f7e30 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 172 | 110 | 5 | cabe7b4131d72da87d3caacd8cced3a4f2cbef53 | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 7.20e-05 | 174 | 110 | 5 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 7.20e-05 | 174 | 110 | 5 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-05 | 176 | 110 | 5 | 0d203682c372411ba64e97a8eae6c4788e8b6ecf | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.60e-05 | 176 | 110 | 5 | a85ad8b4815fde72edd5c900e882a0bc04033ea8 | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 7.81e-05 | 177 | 110 | 5 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-05 | 177 | 110 | 5 | 15553c7cd7826c80086daa76af4224f32dde53a6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-05 | 178 | 110 | 5 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.45e-05 | 180 | 110 | 5 | 1c5515f29ead129bee3b4ca27799796956811a39 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 9.37e-05 | 184 | 110 | 5 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 9.61e-05 | 185 | 110 | 5 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 1.06e-04 | 189 | 110 | 5 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 190 | 110 | 5 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 190 | 110 | 5 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 190 | 110 | 5 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.12e-04 | 191 | 110 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Adult-Immune-natural_killer_cell|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 191 | 110 | 5 | 758ec27e47d7662a5175305e98a1506c6859dbf7 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-04 | 191 | 110 | 5 | 6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-T_reg|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 192 | 110 | 5 | 94e11f68767a899cbcc6984f9398877c1e464abc | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-04 | 193 | 110 | 5 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 194 | 110 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 195 | 110 | 5 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 195 | 110 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 195 | 110 | 5 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 195 | 110 | 5 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 195 | 110 | 5 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-04 | 196 | 110 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 196 | 110 | 5 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.29e-04 | 197 | 110 | 5 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-04 | 197 | 110 | 5 | e4b4fa219322b3250b482f8e242f41e8b05485db | |
| ToppCell | (06)_Krt4/13+-(2)_48hpi|(06)_Krt4/13+ / shred by cell type and Timepoint | 1.32e-04 | 40 | 110 | 3 | 1e42cd186ee06ac9345e16ede649a72c15bdf2f8 | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.32e-04 | 198 | 110 | 5 | 920d2e6603a06c2e8dcb6be127202d222c662bca | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 198 | 110 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 3'_v3-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 1.32e-04 | 198 | 110 | 5 | 807e3ed34739eca159dd0970f884b073e588c649 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | 0f8e2fed93cc103b20a825d8d3e83787c5c015cc | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.38e-04 | 200 | 110 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.38e-04 | 200 | 110 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-04 | 200 | 110 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 | |
| Disease | Calcium channel blocker use measurement | 1.14e-06 | 213 | 107 | 8 | EFO_0009930 | |
| Disease | EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1 | 1.30e-05 | 2 | 107 | 2 | C4722564 | |
| Disease | coronary artery disease (is_implicated_in) | 3.27e-05 | 100 | 107 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Long Qt Syndrome 2 | 3.90e-05 | 3 | 107 | 2 | C3150943 | |
| Disease | Dent disease (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:0050699 (implicated_via_orthology) | |
| Disease | Coronary heart disease | 8.88e-05 | 24 | 107 | 3 | C0010068 | |
| Disease | Depressive Symptoms | 1.13e-04 | 26 | 107 | 3 | C0086132 | |
| Disease | epidermodysplasia verruciformis (is_implicated_in) | 1.29e-04 | 5 | 107 | 2 | DOID:13777 (is_implicated_in) | |
| Disease | neuronal ceroid lipofuscinosis 3 (implicated_via_orthology) | 1.29e-04 | 5 | 107 | 2 | DOID:0110731 (implicated_via_orthology) | |
| Disease | Epidermodysplasia Verruciformis | 1.29e-04 | 5 | 107 | 2 | C0014522 | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 1.94e-04 | 6 | 107 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | osteopetrosis (implicated_via_orthology) | 2.70e-04 | 7 | 107 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | Meckel syndrome (implicated_via_orthology) | 3.60e-04 | 8 | 107 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | Hypercholesterolemia | 3.85e-04 | 39 | 107 | 3 | C0020443 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 4.15e-04 | 40 | 107 | 3 | EFO_0004746 | |
| Disease | Nephronophthisis | 4.61e-04 | 9 | 107 | 2 | cv:C0687120 | |
| Disease | nephronophthisis (implicated_via_orthology) | 4.61e-04 | 9 | 107 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | bipolar disorder, schizophrenia | 4.80e-04 | 42 | 107 | 3 | MONDO_0004985, MONDO_0005090 | |
| Disease | Shortened QT interval | 7.01e-04 | 11 | 107 | 2 | C0151879 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 8.40e-04 | 12 | 107 | 2 | C0403553 | |
| Disease | sialate O-acetylesterase measurement | 8.40e-04 | 12 | 107 | 2 | EFO_0803073 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 8.51e-04 | 51 | 107 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | Hyperlipoproteinemia Type IIb | 9.90e-04 | 13 | 107 | 2 | C1704417 | |
| Disease | Nephronophthisis | 9.90e-04 | 13 | 107 | 2 | C0687120 | |
| Disease | hip bone mineral density, hip bone size | 1.12e-03 | 56 | 107 | 3 | EFO_0004844, EFO_0007702 | |
| Disease | obsolete_red blood cell distribution width | SAMD9 TMC6 APOB SLC4A1 CDH24 CLCN6 ST8SIA6 TMEM259 LPCAT3 TMC8 FBXO7 NT5C2 PAQR3 | 1.19e-03 | 1347 | 107 | 13 | EFO_0005192 |
| Disease | cocaine dependence | 1.24e-03 | 58 | 107 | 3 | EFO_0002610 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.33e-03 | 15 | 107 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Hypertriglyceridemia | 1.33e-03 | 15 | 107 | 2 | C0020557 | |
| Disease | Hyperlipoproteinemia Type IIa | 1.51e-03 | 16 | 107 | 2 | C0745103 | |
| Disease | Moyamoya Disease | 1.71e-03 | 17 | 107 | 2 | C0026654 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 1.71e-03 | 17 | 107 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | hip bone size | 1.72e-03 | 65 | 107 | 3 | EFO_0004844 | |
| Disease | diverticular disease | 1.72e-03 | 236 | 107 | 5 | EFO_0009959 | |
| Disease | myocardial infarction | 1.77e-03 | 350 | 107 | 6 | EFO_0000612 | |
| Disease | Hypercholesterolemia, Familial | 1.92e-03 | 18 | 107 | 2 | C0020445 | |
| Disease | fatty acid measurement, linoleic acid measurement | 1.96e-03 | 68 | 107 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 2.04e-03 | 69 | 107 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | IGF-1 measurement | 2.04e-03 | 488 | 107 | 7 | EFO_0004627 | |
| Disease | Malignant Glioma | 2.13e-03 | 70 | 107 | 3 | C0555198 | |
| Disease | mixed gliomas | 2.13e-03 | 70 | 107 | 3 | C0259783 | |
| Disease | stomach cancer (is_implicated_in) | 2.31e-03 | 72 | 107 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | mean arterial pressure | 2.31e-03 | 499 | 107 | 7 | EFO_0006340 | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.37e-03 | 20 | 107 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | androsterone glucuronide measurement | 2.37e-03 | 20 | 107 | 2 | EFO_0800317 | |
| Disease | erythrocyte measurement | 2.49e-03 | 257 | 107 | 5 | EFO_0005047 | |
| Disease | asthma (is_implicated_in) | 2.60e-03 | 157 | 107 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | Nephritis, Tubulointerstitial | 2.62e-03 | 21 | 107 | 2 | C0041349 | |
| Disease | tissue factor measurement | 2.62e-03 | 21 | 107 | 2 | EFO_0010623 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.87e-03 | 22 | 107 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | preeclampsia | 2.90e-03 | 78 | 107 | 3 | EFO_0000668 | |
| Disease | generalized anxiety disorder | 3.14e-03 | 23 | 107 | 2 | EFO_1001892 | |
| Disease | hippocampal sclerosis of aging | 3.14e-03 | 23 | 107 | 2 | EFO_0005678 | |
| Disease | Nephritis, Interstitial | 3.41e-03 | 24 | 107 | 2 | C0027707 | |
| Disease | airway responsiveness measurement | 3.41e-03 | 24 | 107 | 2 | EFO_0006897 | |
| Disease | Brugada Syndrome (disorder) | 3.41e-03 | 24 | 107 | 2 | C1142166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLKIIALGLSYFFDF | 496 | Q8NEC5 | |
| SYFDLILVDARKPLF | 281 | P49902 | |
| ALDKIAFIPFSYLVD | 1056 | P12821 | |
| LAAVIFIYFAALSPA | 406 | P02730 | |
| LVAIDALSFYLPVKS | 261 | A5X5Y0 | |
| LFASFYLLDFILALV | 61 | Q13304 | |
| LLLAACLPFLAAFYL | 61 | O00270 | |
| AFDSLLAGPVAEYLK | 46 | Q01518 | |
| YLPEFLHTFKITALL | 3206 | Q86UQ4 | |
| PKFRFILLDAYDLSV | 156 | Q3LIE5 | |
| LKSFALLPRLEYNDA | 346 | Q8N9N2 | |
| IFLETLKLYDFFPSC | 251 | P49238 | |
| KDLFLYSSGLFPLLA | 101 | Q5JWR5 | |
| FLNSALRATAPYKFL | 466 | O94923 | |
| ETSNFPKLLLALFLY | 126 | O60706 | |
| PFAEFRKILQFLLAY | 226 | Q5I7T1 | |
| LPATIFLLFLLSAVY | 11 | P11912 | |
| LFLYECATSKAFPLE | 1371 | Q149M9 | |
| SLLYDFLLFPRLKSI | 216 | P30301 | |
| SPVRAYDFLLKFLLV | 6 | Q12829 | |
| IALLAFLFYISKVPE | 246 | Q6TCH7 | |
| FSRILDKSLPADILY | 56 | Q9BX68 | |
| CFVLYKLPNLKFLDA | 106 | Q9H2I8 | |
| YFLADLLVPTKARFP | 381 | O43813 | |
| AAALLPLTSAFYRKL | 631 | Q86WG5 | |
| LSLALLLAVKYIFFE | 326 | P04035 | |
| KDLFLYSCGLFPLLA | 101 | Q9Y3R5 | |
| AKLVYTVLDGLPFFS | 186 | Q86UP0 | |
| ALFALPFVIYAAKVF | 446 | P17181 | |
| PELFQLALKAFRYTL | 1016 | Q63HM2 | |
| ALYPLIALELLDSKF | 936 | O00443 | |
| FLMDLSITYAKPLLF | 1876 | Q6ZR08 | |
| FFLSLLFILPYIHKA | 461 | Q6P1A2 | |
| LSTVPFLAFKHLVYL | 261 | Q7L985 | |
| LDAFLAQALSPKLYE | 736 | Q9NZB2 | |
| HLDKYLAIFDAFITP | 266 | Q8NGB8 | |
| IYLALLVASLPFAFL | 66 | Q9NY59 | |
| IPFFSLLIKDIYFLN | 371 | Q0VAM2 | |
| LKLFCDKYNLIFIPS | 341 | Q5SRI9 | |
| KYLFLLFSDDPNLLS | 666 | Q9UKM7 | |
| LDDLFFTLYPSLEKF | 241 | O75161 | |
| AAKLPVLLNLSFTYL | 216 | O75344 | |
| QLYSKFLLKAEPLAF | 1926 | P04114 | |
| SPVTLALFFVLYFLL | 461 | P51797 | |
| LLKFLPAAVADSGIY | 71 | Q01638 | |
| AALKDYALLTLPAEF | 1486 | Q9P2D3 | |
| FIKSFQALPYVALLI | 1401 | Q13936 | |
| AADYDPFLLFSANLK | 31 | P24387 | |
| RLFKDQLVYPLLAFT | 306 | Q9Y3I1 | |
| ADPFLKYLPSLIAAA | 376 | P78396 | |
| KYLPSLIAAAAFCLA | 381 | P78396 | |
| AFLAVSLVKVFAPYA | 221 | P51795 | |
| YANAELKILALAPTF | 401 | Q12860 | |
| YLLSLIFKAAVDAGF | 131 | Q9NTQ9 | |
| FVLLKALFVLFVLAY | 71 | Q4ZIN3 | |
| SLLFKDPKLAVRLYF | 451 | Q99518 | |
| SFAFFILLVLYPVVD | 576 | Q68CP4 | |
| KLPRVLSLYIFSFLD | 91 | Q8IX29 | |
| QALLSLYKFFAPALI | 236 | Q92674 | |
| VEPAAFLALLKFLYS | 166 | Q9BX70 | |
| YLVLCEAAFPKKLAF | 71 | O75396 | |
| GLVPLKALLDAAAFY | 271 | O95954 | |
| PSLFEHKFLPYALLA | 116 | Q96RD6 | |
| IFIYARPKALSAFDT | 261 | O95222 | |
| YLDAIKLLLDFAAFP | 501 | Q9Y283 | |
| PADIVSFLLTAALYK | 1286 | Q6ZRI0 | |
| KLFSKYLADPSNLFV | 171 | Q9Y316 | |
| PVYFFLKNLSFLDLC | 56 | Q8NHC5 | |
| VLFLSTGFIAYLKPA | 246 | Q8NHC5 | |
| FVFSYLALLLQAKLP | 351 | Q13505 | |
| FYLLKIASFSSPAFL | 106 | Q9NYV9 | |
| LAVFFLFPRSIDVKY | 111 | Q9NUM4 | |
| PVFLAFAKLYIRDIL | 21 | Q9H668 | |
| KLFSFLALLNSYVPD | 916 | Q5K651 | |
| PGLFYLKLSREDFLS | 411 | Q8IZM9 | |
| AATKPDLPTYLLLFF | 46 | A0A1B0GUA5 | |
| VLFFHPKYLKDLALF | 296 | P61647 | |
| YKLPLFIAFIFSTLI | 576 | Q86UG4 | |
| GAYVLAKFALIFPDL | 116 | Q9ULP0 | |
| PFAEFRKILQFLLAY | 226 | Q5BKT4 | |
| IADFIFLLFLPLYIS | 81 | P46091 | |
| AFLTAPLLEFLLALY | 66 | Q96MX0 | |
| LAAFTKLYESLLPFA | 51 | P42695 | |
| FAFLAVSLVKVFAPY | 221 | P51790 | |
| LFKYLAPFLRNVELT | 2071 | A5YKK6 | |
| LLKFYELPALSAEIV | 861 | Q63HN8 | |
| FCKASFLPLLEFAYT | 261 | O95625 | |
| PLLNSVFLFLTFYIK | 496 | Q8IU68 | |
| AKLALYPCASLLAFA | 421 | Q9BSA9 | |
| ALLEPEFILKASLYA | 281 | Q99973 | |
| FLQAYCLAPFDLIKV | 111 | Q8N413 | |
| AELLKIPFVYSLRFS | 161 | P06133 | |
| KLLLPDDFKDFSLLY | 121 | Q96SI1 | |
| FLASLLTEPALVKYF | 1216 | Q6ZT07 | |
| LYLFFVFPLDKDELL | 171 | Q6ZS81 | |
| VLALKLLLYFLASPS | 1641 | Q6ZS81 | |
| LAKYLSIPAVFFLRN | 161 | P35504 | |
| LSLTEFSLPKFYLLF | 2151 | P21359 | |
| LYTFLAASFKELPAN | 346 | Q8N9R8 | |
| KTLFRFSATPALYIL | 101 | Q9UQD0 | |
| FTAYLLAISFSLKPV | 81 | Q3KNW5 | |
| VPALLALAQAYVFLK | 1161 | Q8NDW8 | |
| SFGVLAASILIYFKP | 246 | Q99726 | |
| VKYLIFLSNFPFSLL | 76 | Q9H1Z9 | |
| KSPAFDLFNLVLSYK | 31 | Q5T4F4 | |
| SKAALFLLLAAALTY | 21 | Q9H6L2 | |
| ASFALLYSLLVLKVP | 216 | Q9BY10 | |
| LSYFLFLKTLLAFNA | 246 | Q7Z403 | |
| LVAKALLSYPLPFFA | 386 | Q9H598 | |
| FDAAILLIRNPYKAL | 411 | Q2TBF2 | |
| ALADNAFSPKYLLRL | 931 | Q5JPB2 | |
| YPLFTLVAKLAITLF | 71 | Q9NX78 | |
| LLKALAFVYFVAFLV | 56 | Q96S06 |